SMITH ALAN E - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
CADL on Nasdaq
All Insider Reports
All Insider Reports

Sponsored

There are no Buy or Sell transactions made by SMITH ALAN E since 08 Apr 2025

Holdings reported by SMITH ALAN E for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32,548 $29,293 $0.9000 26 Jul 2021 Direct

Transactions reported by SMITH ALAN E for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.